Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations
- PMID: 31729142
- PMCID: PMC7069771
- DOI: 10.1111/hiv.12820
Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations
Abstract
Objectives: Elite controllers (ECs), viraemic controllers (VCs), and long-term nonprogressors (LTNPs) control HIV viral replication or maintain CD4 T-cell counts without antiretroviral therapy, but may have increased cardiovascular disease (CVD) risk compared to HIV-uninfected persons. We evaluated subclinical carotid and coronary atherosclerosis and inflammatory biomarker levels among HIV controllers, LTNPs and noncontrollers and HIV-uninfected individuals in the Multicenter AIDS Cohort Study (MACS) and the Women's Interagency HIV Study (WIHS).
Methods: We measured carotid plaque presence and common carotid artery intima-media thickness (IMT) in 1729 women and 1308 men, and the presence of coronary artery calcium and plaque in a subgroup of men. Associations between HIV control category and carotid and coronary plaque prevalences were assessed by multivariable regression analyses adjusting for demographics and CVD risk factors. Serum inflammatory biomarker concentrations [soluble CD163 (sCD163), soluble CD14 (sCD14), galectin-3 (Gal-3), galectin-3 binding protein (Gal-3BP) and interleukin (IL)-6] were measured and associations with HIV control category assessed.
Results: We included 135 HIV controllers (30 ECs) and 135 LTNPs in the study. Carotid plaque prevalence and carotid IMT were similar in HIV controllers, LTNPs and HIV-uninfected individuals. HIV controllers and LTNPs had lower prevalences of carotid plaque compared to viraemic HIV-infected individuals. The prevalence of coronary atherosclerosis was similar in HIV controllers/LTNPs compared to HIV-uninfected and viraemic HIV-infected men. Controllers and LTNPs had higher concentrations of sCD163 and sCD14 compared to HIV-uninfected persons.
Conclusions: Subclinical CVD was similar in HIV controllers, LTNPs and HIV-uninfected individuals despite elevated levels of some inflammatory biomarkers. Future studies of HIV controllers and LTNPs are needed to characterize the risk of CVD among HIV-infected persons.
Keywords: AIDS; HIV; carotid atherosclerosis; coronary atherosclerosis; subclinical cardiovascular disease.
© 2019 British HIV Association.
References
-
- Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection. N Engl J Med [Internet]. 1998;338(13):853–60. Available from: http://www.nejm.org/doi/abs/10.1056/NEJM199803263381301 - DOI - PubMed
-
- Wada N, Jacobson LP, Cohen M, French A, Phair J, Muñoz A. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984–2008. Am J Epidemiol. 2013;177(2):116–25. - PMC - PubMed
-
- Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease. J Clin Endocrinol Metab [Internet]. 2007. July [cited 2018 Feb 22];92(7):2506–12. Available from: https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2006-2190 - DOI - PMC - PubMed
-
- Browning KK, Wewers ME, Ferketich AK, Diaz P. Tobacco Use and Cessation in HIV-Infected Individuals. Clin Chest Med [Internet]. 2013. June [cited 2018 Feb 22];34(2):181–90. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0272523113000245 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- U01 AI103397/AI/NIAID NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- R01 HL095140/HL/NHLBI NIH HHS/United States
- K24 AI120834/AI/NIAID NIH HHS/United States
- UM1 AI035043/AI/NIAID NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- U01 AI103401/AI/NIAID NIH HHS/United States
- 5R01 HL095126/HL/NHLBI NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- R01 AI140789/AI/NIAID NIH HHS/United States
- U01 HL146333/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 HL146208/HL/NHLBI NIH HHS/United States
- R01-HL-095140/HL/NHLBI NIH HHS/United States
- R21 HL120394/HL/NHLBI NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- K01-HL-137557/HL/NHLBI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- R01 HL126543/HL/NHLBI NIH HHS/United States
- R01 HL095126/HL/NHLBI NIH HHS/United States
- UL1-TR000004/TR/NCATS NIH HHS/United States
- R01 HL083760/HL/NHLBI NIH HHS/United States
- R01 HL132794/HL/NHLBI NIH HHS/United States
- UL1 RR 025005/RR/NCRR NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- R21-HL-120394/HL/NHLBI NIH HHS/United States
- R01 HL095129/HL/NHLBI NIH HHS/United States
- UL1-TR000124/TR/NCATS NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U01 HL146201/HL/NHLBI NIH HHS/United States
- UL1-TR000454/TR/NCATS NIH HHS/United States
- R21 AG059505/AG/NIA NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- U01 HL146193/HL/NHLBI NIH HHS/United States
- R01-HL-140976/HL/NHLBI NIH HHS/United States
- R01 HL140976/HL/NHLBI NIH HHS/United States
- U01 HL146204/HL/NHLBI NIH HHS/United States
- U01 HL146202/HL/NHLBI NIH HHS/United States
- U01 AI103390/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- R01-HL-126543/HL/NHLBI NIH HHS/United States
- UL1 TR001881/TR/NCATS NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 HL146240/HL/NHLBI NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- U01 AI103408/AI/NIAID NIH HHS/United States
- R01-HL-083760/HL/NHLBI NIH HHS/United States
- R01-HL-132794/HL/NHLBI NIH HHS/United States
- UL1-TR 001079/TR/NCATS NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
- K01 HL137557/HL/NHLBI NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous